Study examines proposed solutions to problems associated with uninsured vehicles and nonregistered motor vehicles in Nebraska and reviews other states' policies and procedures.

Committee reports on interim study resolutions LR 73 (investment of perpetual care trust funds of cemetery associations), LR 78 (Uniform Trustees Powers Act and Uniform Principal and Income Act), LR 151 (federal Bankruptcy Reform Act of 1978: exemptions), LR 153 (industrial loan and investment companies), and LR 64, 103 (determination of automobile liability insurance rates likely to result from changes in Nebraska's tort liability laws--including adoption of "no-fault").

Committee report on interim study resolutions LR 77, 164 (special education), LR 110 (transportation of school children), LR 111 (capital construction needs of technical-community colleges), LR 120 (establishment of joint school of veterinary medicine--no action), LR 124 (competency-based educational testing), LR 131 (State Department of Education), LR 139 (State aid to education).

There has been substantial growth in the use of data monitoring committees in recent years, by both government agencies and the pharmaceutical industry. This growth has been brought about by increasing recognition of the value of such committees in safeguarding trial participants as well as protecting trial integrity and the validity of conclusions. This very timely book describes the operation of data monitoring committees, and provides an authoritative guide to their establishment, purpose and responsibilities. * Provides a practical overview of data monitoring in clinical trials. * Describes the purpose, responsibilities and operation of data monitoring committees. * Provides directly applicable advice for those managing and conducting clinical trials, and those serving on data monitoring committees. * Gives insight into clinical data monitoring to those sitting on regulatory and ethical committees. * Discusses issues pertinent to those working in clinical trials in both the US and Europe. The practical guidance provided by this book will be of use to professionals working in and/or managing clinical trials, in academic, government and industry settings, particularly medical statisticians, clinicians, trial co-ordinators, and those working in regulatory affairs and bioethics.